4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0000950170-25-080885
Options or other derivatives
- Chief Commercial Officer acquired 72,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Simon Farrell Chief Commercial Officer | 2025-05-31 | Grant or award · Performance Stock Option (right to buy) | +72,000 | 110,400 | D | ||
Loading xslF345X05/ownership.xml…